1. Home
  2. SFHG vs ACXP Comparison

SFHG vs ACXP Comparison

Compare SFHG & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SFHG

Samfine Creation Holdings Group Limited Ordinary Share

HOLD

Current Price

$2.58

Market Cap

10.3M

ML Signal

HOLD

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

HOLD

Current Price

$1.94

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SFHG
ACXP
Founded
1993
2017
Country
Hong Kong
United States
Employees
226
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.3M
8.3M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
SFHG
ACXP
Price
$2.58
$1.94
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$95.50
AVG Volume (30 Days)
10.2K
105.2K
Earning Date
10-30-2025
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.32
$0.29
52 Week High
$3.17
$8.34

Technical Indicators

Market Signals
Indicator
SFHG
ACXP
Relative Strength Index (RSI) 55.25 41.64
Support Level $2.29 $1.82
Resistance Level $2.60 $2.30
Average True Range (ATR) 0.16 0.15
MACD -0.00 0.04
Stochastic Oscillator 82.72 42.55

Price Performance

Historical Comparison
SFHG
ACXP

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: